Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Public Health

Can you get tuberculosis twice?

John Hoey
CMAJ February 19, 2002 166 (4) 478;
John Hoey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Metrics
  • Responses
  • PDF
Loading

Background and epidemiology: First exposure to tuberculosis (TB) usually results in a clinically silent infection. Often the only sign is a positive reaction to a skin test with purified protein derivative. Most clinically relevant TB is thought to be a postprimary infection caused by the reactivation of a previously dormant primary (endogenous) infection. There have been some reports of exogenous reinfection with multiple-drug–resistant strains of Mycobacterium tuberculosis, but these were restricted to HIV-positive patients who were immunocompromised.1

Figure1

Figure. Recurrent turberculosis due to reinfection in South Africa: Implications for Canada? Photo by: Art Explosion

However, findings from a study conducted in 2 poor suburban communities in Cape Town, South Africa, suggest that reinfection may be more common than previously thought.2 Participants had had an episode of postprimary TB treated and cured between 1992 and 1998 that was followed by a second, new episode of postprimary disease. The study is unique for its careful attention to documenting the first cure and the fact that sputum samples were available for DNA fingerprinting of tuberculosis organisms by means of restriction fragment length polymorphism (RFLP) analysis.

Although the rates of TB infection were high in these communities and many patients had at least 2 episodes of postprimary infection, only 16 patients had their M. tuberculosis organisms genotyped by means of RFLP. For 12 of the 16 patients the banding patterns of the organisms in the 2 episodes were different: they had been reinfected with an exogenous (new) organism. The authors were able to confirm that 15 of the 16 participants did not have HIV antibodies. In this region of South Africa, TB reinfection after an initial infection has been cured appears to be an important cause of postprimary infection and may be responsible for up to 75% of cases of postprimary disease (95% confidence interval 50%–94%).

Clinical management: Currently in North America, elderly people in whom clinical TB develops are assumed to have a reactivated earlier infection. The findings from the South Africa study strongly suggest that at least some of the cases that are identified as being endogenous reactivation may in fact be exogenous reinfection. These results may have implications for TB control in North America. For example, a clinician who has an elderly patient with TB may be less certain that the offending strain was acquired by the patient decades earlier and is, therefore, sensitive to standard drug therapy. If the infection is indeed new, the organism is more likely to be resistant to therapy. Also, it may be prudent to provide chemoprophylaxis for people exposed to a patient with active TB, even if the patient has a history of previous infection.2

Nonetheless, the primary management strategy must still be the treatment of clinical infection, regardless of whether it was acquired endogenously or exogenously. Directly observed short-course treatment (DOTS) and the associated strategies for isolating the patient and identifying contacts remain the current mainstay of modern TB control and treatment.3

Control and prevention: The findings from South Africa, especially if confirmed in other populations (a report from the Netherlands4 suggests that exogenous reinfection may be very rare, perhaps related to the probability of exposure5), have implications for public health. First, public health physicians should no longer presume that TB in an elderly person is simply due to reactivation of a previous infection. The possibility that the patient has a newly acquired infection will require a diligent search in the community for the source of the infection. Second, if primary infection does not convey immunity to subsequent infection with an organism of a different genotype, then there are implications for efforts to develop a vaccine against TB. A vaccine against a single genotype may not be effective. To improve their investigation of new cases, public health epidemiologists in North America should consider the need to genotype TB strains in all cases.

John Hoey CMAJ

References

  1. 1.↵
    Fine PEM, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med 1999;341:1226-7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341: 1174-9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Hershfield E. Tuberculosis: 9. Treatment. CMAJ 1999;161(4):405-11. Available: www .cma .ca /cmaj/vol-161/issue-4/0405.htm
    OpenUrlFREE Full Text
  4. 4.↵
    De Boer AS, van Soolingen D, Borgdorff MW. Recurrent tuberculosis due to exogenous reinfection [letter]. N Engl J Med 2000;342:1050-1.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Van Rie V, Warren R, van Helden R. Recurrent tuberculosis due to exogenous reinfection [response]. N Engl J Med 2000;342:1051.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 166, Issue 4
19 Feb 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can you get tuberculosis twice?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Can you get tuberculosis twice?
John Hoey
CMAJ Feb 2002, 166 (4) 478;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Can you get tuberculosis twice?
John Hoey
CMAJ Feb 2002, 166 (4) 478;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Seasonal drinking: Let's avoid the “January effect”
  • Influenza in children
  • Latent tuberculosis: revised treatment guidelines
Show more Public Health

Similar Articles

Collections

  • Topics
    • Infectious diseases
    • Global health

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, CMA Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire